Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Almirall S a patents

Recent patent applications related to Almirall S a. Almirall S a is listed as an Agent/Assignee. Note: Almirall S a may have other listings under different names/spellings. We're not affiliated with Almirall S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Almirall S a-related inventors




Date Almirall S a patents (updated weekly) - BOOKMARK this page
09/28/17New bicyclic derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
07/06/17Medical use
06/08/17Addition salts of (s)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile
06/01/17Combination
05/11/17Novel dosage and formulation
11/17/16New use of aclidinium
10/27/16Pharmaceutical compositions comprising dimethyl fumarate
10/27/16Pharmaceutical compositions comprising dimethyl fumarate
10/20/16Novel dosage form and formulation of abediterol
10/13/16Novel quinuclidine derivatives and medicinal compositions containing the same
09/15/16Aclidinium for use in improving the quality of sleep in respiratory patients
09/15/16New cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities
07/14/16New cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities
06/23/16Combinations comprising maba compounds and corticosteroids
06/16/16Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both muscarinic receptor antagonist and beta2 adrenergic receptor agonist activities
05/26/16New cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities
02/11/16Topical pharmaceutical compositions
01/21/16Combinations comprising maba compounds and corticosteroids
01/14/16Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both β2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities
11/19/15New use of aclidinium
11/19/15New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
10/29/15New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
10/15/15Pyrrolotriazinone derivatives as pi3k inhibitors
09/03/15Novel quinuclidine derivatives and medicinal compositions containing the same
05/21/15Novel dosage form and formulation of abediterol
04/30/15Novel dosage and formulation
04/30/15Pyrazole derivatives as jak inhibitors
04/23/15Topical pharmaceutical compositions
04/02/15Novel methods
03/05/15Salts of 5-[(1r)-2-(amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
02/26/15Novel polymorphic crystal forms of 5-(2--1-(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisytlate as agonist of the beta2 adrenergic receptor
01/08/15Process for preparing 5-(2--1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate
01/01/15Inhalation device for powdered drugs
12/25/14Inhalation device for powdered drugs
12/25/14Inhalation device for powdered drugs
12/25/14New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
11/27/14Topical pharmaceutical compositions comprising bexarotene and a corticosteroid
11/20/145-(2-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one for the treatment of lung function
09/18/14Pyridin-2(1h)-one derivatives as jak inhibitors
06/19/14Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
02/06/145-(2--1-hydroxyethyl-8-hydroxyquinolin-2 (1h)-one and its use in the treatment of pulmonary diseases
01/02/14Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
11/21/13Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
07/25/13Novel dosage and formulation
05/23/13Novel dosage and formulation
02/28/13Storage system for powdered pharmaceuticals, and inhaler equipped with this system
02/02/125-(2--1-hydroxyethyl)-8-hydroxyquinolin-2 (1h)-one for the treatment of lung function
12/22/111,2,4-oxadiazole derivatives and their therapeutic use
10/13/11Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
09/01/11Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Almirall S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Almirall S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';